Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Q1 2025 earnings

Reported May 5, 2025 · Before market open

Revenue$585.4MBeat by $12.2MDiluted EPS$2.29Beat by $0.47
Revenue estimate$573.2M
EPS estimate$1.82

Next report

Jul 30, 2026 (in a month)
Revenue estimate$624.8M
EPS estimate$1.78

Financials

Q1 2025

Income statement

See full
Revenue$585.4M-4.2%
Gross profit$306.0M-6.1%
Operating income$23.7M-46.9%
Net income$64.0M-83.3%
EPS (diluted)$2.29-83.0%

Balance sheet

See full
Cash & equivalents$523.1M+20.6%
Total debt$1.4B-2.2%
Total equity$6.7B-26.2%
Total assets$9.5B-24.4%

Cash flow

See full
Operating cash flow$129.9M+86.1%
CapEx$34.4M-14.4%
Free cash flow$95.5M+223%

Valuation & ratios

Q1 2025

Valuation

See full
Market cap$6.82B-30.8%
Enterprise value$7.68B-29.2%
P/S2.7×-1.1×

Profitability

See full
Gross margin53.5%+0.1pp
Operating margin9.8%-2.5pp
Net margin-85.2%-103pp
FCF margin14%+6.9pp

Returns & leverage

See full
Return on equity-27.5%-32.1pp
Debt / equity0.2×+0.1×
Current ratio6×-0.6×

Segments

By segment

See full
Clinical Diagnostics$356.8M-3.2%
Life Science$228.6M-5.4%
All Other Segments--100%

By geography

See full
Europe$199.8M-0.2%
Asia Pacific$104.1M-11.2%
Americas$39.8M-1.7%

Versus estimates

Revenue

Q1 2026$592.1MBeat by $784.1KQ4 2025$693.2MBeat by $5.2MQ3 2025$653.0MBeat by $1.5MQ2 2025$651.6MMiss by $55.0M
Q1 2025$585.4MBeat by $12.2M
Q4 2024$667.5MMiss by $12.3M

Diluted EPS

Q1 2026$1.89Miss by $0.12Q4 2025$2.51Miss by $0.18Q3 2025-$12.70Miss by $14.59Q2 2025$11.67Beat by $9.92
Q1 2025$2.29Beat by $0.47
Q4 2024-$25.57Miss by $28.43

Ask the moment Bio-Rad Laboratories, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Rad Laboratories, Inc. report Q1 2025 earnings?
Bio-Rad Laboratories, Inc. (BIO.B) reported Q1 2025 earnings on May 5, 2025 before market open.
What were Bio-Rad Laboratories, Inc.'s Q1 2025 revenue and EPS?
Bio-Rad Laboratories, Inc. reported revenue of $585.4M and diluted EPS of $2.29 for Q1 2025.
Did Bio-Rad Laboratories, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $573.2M by $12.2M. EPS beat the consensus estimate of $1.82 by $0.47.
How did Bio-Rad Laboratories, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.2% from $610.8M a year earlier and diluted EPS declined 83.0% from $13.45.
Where can I find Bio-Rad Laboratories, Inc.'s Q1 2025 SEC filings?
You can read the 10-Q periodic report (0000012208-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.